Ethics and Policy Core

道德和政策核心

基本信息

项目摘要

The ever-growing and evolving HIV epidemic in both the US and the developing world continues to pose numerous critical ethical and policy issues. These are becoming all the more acute as researchers begin work in unfamiliar settings and with new populations in the developing world. Further, given the particular vulnerability of people living with or at high risk of HIV, it is especially crucial that HIV-related research be conducted according to stringent ethical standards. The Ethics and Policy Core (EPC) will enhance the Center's ability to address these issues through three overall functions of providing consultation, fostering education, and conducting empirical research on two broad areas: 1) policy issues at multiple levels- international, national, local, institutional and professional (i.e., including policies in various health care institutions and settings), and 2) ethics of research with people who are infected with or at risk for infection with HIV. The EPC builds on the past work of the HIV Center in ethics and policy and will also incorporate new emphases on research ethics and the relationship between policy and economics. The EPC will consult with Center investigators concerning policy implications and research ethics related to their work as they conduct research, develop new research initiatives, prepare grants and IRB applications, analyze findings, and write manuscripts. The EPC will also provide and enhance education on ethical and policy issues among investigators and trainees in the Center and in broader communities through seminars, conferences and roundtable discussions, as well as a Program in Applied Ethics for newer investigators. The Core will also conduct research either through stand-alone studies or by adding studies of ethical and policy questions onto existing Center research studies. The Core will help identify ethical and policy issues that need to, and can, be studied empirically, and can be pursued by Pis (either from the Core or the rest of the Center). Thus, the Core will add significantly to the Center as a whole, infusing into the Center critical expertise and activities in these areas that can help expand understandings and approaches in policy, research ethics, and numerous other domains within the broad area of HIV prevention and treatment. Specifically, the Core will enable Center investigators, in key ways they would not otherwise, develop policy implications of their work, promote the practice and understanding of research ethics, examine crucial policy issues using empirical approaches.
美国和发展中国家不断增长和演变的艾滋病毒流行病继续构成 许多关键的道德和政策问题。随着研究人员开始 在不熟悉的环境中工作,并与发展中国家的新人口一起工作。此外,鉴于具体 艾滋病毒感染者或高危人群的脆弱性,尤其重要的是, 必须按照严格的道德标准进行。道德和政策核心(EPC)将加强 该中心的能力,以解决这些问题,通过三个整体职能提供咨询, 促进教育,并在两个广泛领域进行实证研究:1)多个领域的政策问题 各级----国际、国家、地方、机构和专业(即,包括各种卫生政策, 护理机构和环境),以及2)与感染或有感染风险的人进行研究的伦理 感染艾滋病毒。伦理委员会建立在艾滋病毒中心过去在伦理和政策方面的工作基础上, 将研究伦理和政策与经济学之间的关系纳入新的重点。的 EPC将与中心研究人员就以下相关的政策影响和研究伦理进行磋商: 他们的工作,因为他们进行研究,开发新的研究计划,准备赠款和IRB 应用程序,分析结果,并撰写手稿。EPC还将提供和加强教育 在中心和更广泛的社区的调查人员和受训人员中讨论道德和政策问题 通过研讨会、会议和圆桌讨论,以及应用伦理学项目, 新的调查员。核心小组还将通过独立研究或增加 伦理和政策问题的研究,以现有的中心研究。核心将帮助识别 伦理和政策问题,需要,并且可以,进行实证研究,并可以追求的PI(或 从核心或中心的其余部分)。因此,核心将大大增加整个中心, 为中心注入这些领域的关键专业知识和活动, 在政策,研究伦理和广泛的其他许多领域的理解和方法 艾滋病防治领域。具体而言,核心将使中心的调查人员,在关键方面, 否则,他们就不会发展其工作的政策影响,促进这种做法, 研究伦理的理解,使用实证方法研究关键的政策问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT L KLITZMAN其他文献

ROBERT L KLITZMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT L KLITZMAN', 18)}}的其他基金

Ethics and Policy Core
道德和政策核心
  • 批准号:
    8015618
  • 财政年份:
    2010
  • 资助金额:
    $ 22.8万
  • 项目类别:
IRBs: Ethics, Context and Interpretations
IRB:道德、背景和解释
  • 批准号:
    8144256
  • 财政年份:
    2009
  • 资助金额:
    $ 22.8万
  • 项目类别:
Ethics and Policy Core
道德和政策核心
  • 批准号:
    7900718
  • 财政年份:
    2009
  • 资助金额:
    $ 22.8万
  • 项目类别:
IRBs: Ethics, Context and Interpretations
IRB:道德、背景和解释
  • 批准号:
    7938870
  • 财政年份:
    2009
  • 资助金额:
    $ 22.8万
  • 项目类别:
IRBs: Ethics, Context and Interpretations
IRB:道德、背景和解释
  • 批准号:
    7620223
  • 财政年份:
    2009
  • 资助金额:
    $ 22.8万
  • 项目类别:
Views and Approaches Toward Research Integrity Among IRBs
IRB 对研究诚信的看法和方法
  • 批准号:
    7124890
  • 财政年份:
    2006
  • 资助金额:
    $ 22.8万
  • 项目类别:
Views and Approaches Toward Research Integrity Among IRBs
IRB 对研究诚信的看法和方法
  • 批准号:
    7287439
  • 财政年份:
    2006
  • 资助金额:
    $ 22.8万
  • 项目类别:
Views of Privacy of Genetic Information
对遗传信息隐私的看法
  • 批准号:
    6620621
  • 财政年份:
    2002
  • 资助金额:
    $ 22.8万
  • 项目类别:
Views of Privacy of Genetic Information
对遗传信息隐私的看法
  • 批准号:
    6419830
  • 财政年份:
    2002
  • 资助金额:
    $ 22.8万
  • 项目类别:
Views of Privacy of Genetic Information
对遗传信息隐私的看法
  • 批准号:
    6849753
  • 财政年份:
    2002
  • 资助金额:
    $ 22.8万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了